Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin

AAPS PharmSciTech

Volumn 12, Issue 3, 2011, Pages 958-964

  Elsayed, Amani ^a,c   Al Remawi, Mayyas ^c   Qinna, Nidal ^d   Farouk, Asim ^a   Al Sou'Od, Khaldoun A ^e   Badwan, Adnan A ^b  

^a UNIVERSITY OF GEZIRA   (Sudan)

^b Subsidiary of the Jordanian Pharmaceutical Manufacturing Co   (Jordan)

^c TAIF UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF PETRA   (Jordan)

^e AL AL BAYT UNIVERSITY   (Jordan)

Author keywords

chitosan; insulin; nanoparticles; oral delivery system; sodium lauryl sulfate

Indexed keywords

CHITOSAN; DODECYL SULFATE SODIUM; GLUCOSE; INSULIN; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GELATION; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH JUICE;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CHITOSAN; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; INSULIN; MALE; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; SODIUM DODECYL SULFATE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL;

EID: 80052599281     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9647-5     Document Type: Article

References (34)

1. K Yamauchi 2009 Analysis of issues of insulin self-injection in elderly Nippon Ronen Igakkai Zasshi (Japanese). 46 6 537 40 20139650 10.3143/geriatrics.46.537
2. R Rubin M Peyrot D Kruger L Travis 2009 Barriers to insulin injection therapy: patient and health care provider perspectives Diabetes Educ 35 1014 22 19934459 10.1177/0145721709345773
3. L Mastrandrea 2010 Inhaled insulin: overview of a novel route of insulin administration Vasc Health Risk Manag 6 47 58 20234779 10.2147/VHRM.S6098 1:CAS:528:DC%2BC3cXhtlGksbg%3D
4. Y Chien 1996 Human insulin: basic sciences to therapeutic uses Drug Dev Ind Pharm 22 753 789 10.3109/03639049609065908 1:CAS:528:DyaK28XkvVeqs7g%3D (Pubitemid 26272584)
5. R Krishnankutty A Mathew S Sedimbi S Suryanarayan C Sanjeevi 2009 Alternative routes of insulin delivery Zhong Nan Da Xue Xue Bao Yi Xue Ban 34 933 48 19893243 1:CAS:528:DC%2BC3cXivVagsrY%3D
6. F Gomez-Perez J Rull 2005 Insulin therapy: current alternatives Arch Med Res 36 258 272 15925016 10.1016/j.arcmed.2005.03.012 1:CAS:528: DC%2BD2MXks1Cnurg%3D (Pubitemid 40755139)
7. C Bailey A Barnett 2007 Why is Exubera being withdrawn BMJ 335 1156 10.1136/bmj.39409.507662.94
8. E Arbit 2004 The physiological rationale for oral insulin administration Diabetes Tech. Therap. 6 510 517 10.1089/1520915041705929 1:CAS:528: DC%2BD2cXmslWhsLw%3D (Pubitemid 39121378)
9. G Carino E Mathiowitz 1999 Oral insulin delivery Adv. Drug Del. Rev. 35 249 257 10.1016/S0169-409X(98)00075-1 1:CAS:528:DyaK1MXksFehuw%3D%3D (Pubitemid 29073617)
10. T Nagamoto Y Hattori K Takayama, et al. 2004 Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery Pharm Res 21 671 674 15139524 10.1023/B:PHAM.0000022414.17183.58 1:CAS:528:DC%2BD2cXjsVWqs7o%3D (Pubitemid 38457290)
11. Y Ohya T Takei H Kobayashi, et al. 1993 Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition J Microencapsul 10 1 9 8383199 10.3109/02652049309015307 1:CAS:528: DyaK3sXktlCiurg%3D (Pubitemid 23069809)
12. S Mao U Bakowsky A Jintapattanakit, et al. 2006 Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin J Pharm Sci 95 1035 1048 16565978 10.1002/jps.20520 1:CAS:528:DC%2BD28Xkslejtbk%3D (Pubitemid 43723163)
13. M Lavertu S Methot N Tran-Khanh, et al. 2006 High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation Biomaterials 27 4815 4824 16725196 10.1016/j.biomaterials.2006.04.029 1:CAS:528:DC%2BD28XlsFCru78%3D (Pubitemid 43880352)
14. Sung, Hsing-wen, Lin, Yu-hsin Liang, Hsiang-faTu, Hosheng. Nanoparticles for protein drug delivery. US patent. Publication number (US 2008/0213354 A1). Publication date: 09/04/2008
15. B Sarmento AJ Ribeiro F Veiga, et al. 2007 Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation J Nanosci Nanotechnol 7 2833 2841 17685304 10.1166/jnn.2007.609 1:CAS:528:DC%2BD2sXot1entbw%3D
16. ZT Ma T Lim L Lim 2005 Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats Int J Pharm 293 271 280 15778065 10.1016/j.ijpharm.2004.12.025 1:CAS:528:DC%2BD2MXitlSgtbc%3D (Pubitemid 40381099)
17. YH Lin FL Mi CT Chen, et al. 2007 Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery Biomacromolecules 8 146 152 17206800 10.1021/bm0607776 1:CAS:528:DC%2BD28Xht1yiurrL (Pubitemid 46140485)
18. MR Rekha CP Sharma 2009 Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption J Control Release 135 2 144 15 19331862 10.1016/j.jconrel.2009.01.011 1:CAS:528: DC%2BD1MXjslWqsr0%3D
19. M Qandil A Obaidat M Ali B Al-taani B Tashtoush N Al-Jbour M Al-Remawi K Al-Souod A Badwan 2009 Investigation of the Interactions in Complexes of Low Molecular Weight Chitosan with Ibuprofen J Sol. Chem. 38 695 712 10.1007/s10953-009-9405-4 1:CAS:528:DC%2BD1MXltlOjur8%3D
20. Badwan A., Al-Remawi M, Eltaher T, Elsayed A. Oral delivery of protein drug using microemulsion. International patent (WO2007/068311) date of publication 21 June 2007.
21. A Elsayed MA Remawi N Qinna A Farouk A Badwan 2009 Formulation and characterization of an oily-based system for oral delivery of insulin Eur J Pharm Biopharm 73 269 279 19508890 10.1016/j.ejpb.2009.06.004 1:CAS:528:DC%2BD1MXhtFyhtLbP
22. N Edkidik M Remawi N Qinna A Elsayed A Farouk A Badwan 2009 Enhancement of oral bioavailability of insulin in humans Neuroendocrinol Lett. 30 101 105
23. X Xu Y Fu H Hu, et al. 2006 Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography J Pharm Biomed Anal 41 266 273 16303273 10.1016/j.jpba.2005.10.016 1:CAS:528:DC%2BD28Xis1entbs%3D
24. A Sadeghi FM Dorkoosh M Avadi, et al. 2008 Preparation, characterization and antibacterial activities of chitosan, Ntrimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC)nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods Int J Pharm 355 299 306 18206322 10.1016/j.ijpharm.2007.11.052 1:CAS:528:DC%2BD1cXkt1ygsLg%3D
25. I El Gibaly AM Meki SK Abdel-Ghaffar 2003 Novel B melatonin-loaded chitosan microcapsules: in vitro characterization and antiapoptosis efficacy for aflatoxin B1-induced apoptosis in rat liver Int J Pharm 260 5 22 12818806 10.1016/S0378-5173(03)00149-2 (Pubitemid 36724857)
26. A Berthold K Cremer J Kreuter 1996 Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs J Control Release 39 17 25 10.1016/0168-3659(95) 00129-8 1:CAS:528:DyaK28XjtFSktL8%3D
27. HL Jiang IK Park NR Shin, et al. 2004 Controlled release of Bordetella bronchiseptica dermonecrotoxin (BBD) vaccine from BBD-loaded chitosan microspheres in vitro Arch Pharm Res 27 346 350 15089042 10.1007/BF02980071 1:CAS:528:DC%2BD2cXivFCmtbs%3D (Pubitemid 43073759)
28. S Sajeesh CP Sharma 2006 Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery Int J Pharm 325 147 154 16859846 10.1016/j.ijpharm.2006.06.019 1:CAS:528:DC%2BD28XhtFSgsrrJ (Pubitemid 44573692)
29. S Zhu F Qian Y Zhang, et al. 2007 Synthesis and characterization of PEG modified N-trimethylaminoethylmethacrylate chitosan nanoparticles Eur Polym J. 43 2244 2253 10.1016/j.eurpolymj.2007.03.042 1:CAS:528:DC%2BD2sXmt1Kis7Y%3D (Pubitemid 46856403)
30. KA Janes P Calvo MJ Alonso 2001 Polysaccharide colloidal particles as delivery systems for macromolecules Adv Drug Deliv Rev 47 83 97 11251247 10.1016/S0169-409X(00)00123-X 1:CAS:528:DC%2BD3MXhvVajsrY%3D (Pubitemid 32209234)
31. S Sakuma N Suzuki H Kikuchi, et al. 1997 Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches Int J Pharm 149 93 106 10.1016/S0378-5173(96)04861-2 1:CAS:528:DyaK2sXjsVGjtbw%3D (Pubitemid 27193422)
32. WG Dai LC Dong 2007 Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing Int J Pharm 336 58 66 17174492 10.1016/j.ijpharm.2006.11.035 1:CAS:528:DC%2BD2sXktFOmtb0%3D (Pubitemid 46551556)
33. Z Ma H Yeoh LY Lim 2002 Formulation pH modulates the interaction of insulin with chitosan nanoparticles J Pharm Sci 91 1396 1404 12115839 10.1002/jps.10149 1:CAS:528:DC%2BD38XktlWrsrk%3D (Pubitemid 34633955)
34. J Berger M Reist JM Mayer, et al. 2004 Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications Eur J Pharm Biopharm 57 35 52 14729079 10.1016/S0939-6411(03)00160- 7 1:CAS:528:DC%2BD2cXjsFaksg%3D%3D (Pubitemid 38058802)